Advertisement

Surgical Techniques for Metastatic Hepatic Carcinoma

Chapter

Abstract

Hepatic metastasis of colorectal cancer is a critical factor affecting prognosis of colorectal cancer. For about 25 % of patients, hepatic metastasis had occurred when colorectal cancer was confirmed; for 40–50 % of patients, it would occur within 3 years after surgery for colorectal cancer [1]. Surgical therapy is the only means by which radical treatment can be achieved. With the improvement of surgical techniques today, the 5-year survival rate has increased to 45–60 %, from 30 to 35 % in the 1990s [2].

Keywords

Portal Vein Hepatic Vein Inferior Vena Liver Parenchyma Portal Vein Embolization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    O’Reilly DA, Poston GJ. Colorectal liver metastases: current and future perspectives. Future Oncol. 2006;2(4):525–31.CrossRefPubMedGoogle Scholar
  2. 2.
    De Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg. 2009;250(3):440–8.PubMedGoogle Scholar
  3. 3.
    Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut. 2006;55 Suppl 3:iii1–8.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Imamura H, Seyama Y, Kokudo N, et al. Single and multiple resections of multiple hepatic metastases of colorectal origin. Surgery. 2004;135(5):508–17.CrossRefPubMedGoogle Scholar
  5. 5.
    Capussotti L, Vigano’ L, Ferrero A, et al. Timing of resection of liver metastases synchronous to colorectal tumor: proposal of prognosis-based decisional model. Ann Surg Oncol. 2007;14(3):1143–50.CrossRefPubMedGoogle Scholar
  6. 6.
    Martin 2nd RC, Augenstein V, Reuter NP, et al. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg. 2009;208(5):842–50.CrossRefPubMedGoogle Scholar
  7. 7.
    Peeters CF, de Waal RM, Wobbes T, et al. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer. 2006;119(6):1249–53.CrossRefPubMedGoogle Scholar
  8. 8.
    Otchy D, Hyman NH, Simmang C, et al. Practice parameters for colon cancer. Dis Colon Rectum. 2004;47(8):1269–84.CrossRefPubMedGoogle Scholar
  9. 9.
    Kong G, Jackson C, Koh DM, et al. The use of 18F-FDG PET/CT in colorectal liver metastases – comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging. 2008;35(7):1323–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Lubezky N, Metser U, Geva R, et al. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg. 2007;11(4):472–8.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Adie S, Yip C, Chu F, et al. Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning? ANZ J Surg. 2009;79(5):358–61.CrossRefPubMedGoogle Scholar
  12. 12.
    Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24(13):2065–72.CrossRefPubMedGoogle Scholar
  13. 13.
    Rubbia-Brandt L, Mentha G, Terris B. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg. 2006;202(1):199–200.CrossRefPubMedGoogle Scholar
  14. 14.
    Zacherl J, Scheuba C, Imhof M, et al. Current value of intraoperative sonography during surgery for hepatic neoplasms. World J Surg. 2002;26(5):550–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Pawlik TM, Vauthey JN. Surgical margins during hepatic surgery for colorectal liver metastases: complete resection not millimeters defines outcome. Ann Surg Oncol. 2008;15(3):677–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Hamady ZZ, Cameron IC, Wyatt J, et al. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol. 2006;32(5):557–63.CrossRefPubMedGoogle Scholar
  17. 17.
    DeMatteo RP, Palese C, Jarnagin WR, et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg. 2000;4(2):178–84.CrossRefPubMedGoogle Scholar
  18. 18.
    Zorzi D, Mullen JT, Abdalla EK, et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg. 2006;10(1):86–94.CrossRefPubMedGoogle Scholar
  19. 19.
    Sarpel U, Bonavia AS, Grucela A, et al. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol. 2009;16(2):379–84.CrossRefPubMedGoogle Scholar
  20. 20.
    Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002;235(6):863–71.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Adam R, Pascal G, Azoulay D, et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003;238(6):871–83.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht and People's Medical Publishing House 2017

Authors and Affiliations

  1. 1.Zhongshan Hospital, Fudan UniversityShanghaiChina

Personalised recommendations